[1] 陈从新, 郭顺明, 刘波, 等.糖皮质激素阻断慢性乙型肝炎肝衰竭发生的临床对照观察. 中华肝脏病杂志,2003,11(1): 37-40. [2] 中华医学会感染病学分会肝衰竭与人工肝学组和肝病学分会重型肝病与人工肝学组.肝衰竭诊疗指南.实用肝脏病杂志,2006,9:321-324. [3] 中华医学会感染病学分会肝衰竭与人工肝学组;中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版).实用肝脏病杂志,2019,22(2):164-171. [4] 范文瀚,罗怡平,李成忠.糖皮质激素应用于肝衰竭治疗机制及其临床时机的把握. 实用肝脏病杂志,2020,23(1):6-8. [5] 纪宇欣,李树臣.应用糖皮质激素治疗肝衰竭临床疗效研究进展. 实用肝脏病杂志,2020,23(1):9-12. [6] Harputluo 8, Temel 813, Seçkin Y, et al. Methylprednisolone prevents bacterial translocation in thioacetamide-induced liver failure in rats. Turk J Gastroenterol. 2017,28(5):394-400. [7] Yasui S, Fujiwara K, Haga Y, et al. Infectious complications, steroid use and timing for emergency liver transplantation in acute liver failure: analysis in a Japanese center. J Hepatobiliary Pancreat Sci, 2016,23(12):756-762. [8] Wan YM, Wu JF, Li YH, et al. Prednisone is not beneficial for the treatment of severe drug-induced liver injury: An observational study (STROBE compliant). Medicine (Baltimore), 2019,98(26):e15886. |